{
  "ticker": "JNJ",
  "target_date": "2025-08-12",
  "actual_date": "2025-08-12",
  "collected_at": "2025-12-08T12:07:50.885363",
  "price": {
    "open": 171.64,
    "high": 172.39,
    "low": 169.48,
    "close": 170.43887329101562,
    "volume": 7916700,
    "change_1d_pct": -0.6,
    "change_7d_pct": 3.26,
    "change_30d_pct": 13.11
  },
  "technicals": {
    "rsi_14": 59.16,
    "sma_20": 166.13,
    "sma_50": 157.89,
    "macd": 3.832,
    "macd_signal": 3.666,
    "macd_histogram": 0.166,
    "bb_upper": 172.59,
    "bb_lower": 159.67,
    "price_vs_sma20_pct": 2.59,
    "price_vs_sma50_pct": 7.95,
    "volume_ratio": 0.84
  },
  "fundamentals": {
    "market_cap": 488906227712,
    "pe_ratio": 19.587357,
    "forward_pe": 19.143867,
    "price_to_book": 6.159135,
    "price_to_sales": 5.3056054,
    "profit_margin": 27.26,
    "operating_margin": 30.2,
    "roe": 33.62,
    "roa": 8.26,
    "revenue_growth": 6.8,
    "earnings_growth": 91.0,
    "debt_to_equity": 57.766,
    "current_ratio": 1.074,
    "quick_ratio": 0.711,
    "dividend_yield": 258.0,
    "fifty_two_week_high": 207.81,
    "fifty_two_week_low": 140.68,
    "fifty_day_avg": 193.4922,
    "two_hundred_day_avg": 170.2741,
    "analyst_target": 203.41833,
    "analyst_recommendation": "buy",
    "num_analysts": 24,
    "sector": "Healthcare",
    "industry": "Drug Manufacturers - General",
    "pct_from_52w_high": -2.35,
    "pct_from_52w_low": 44.25
  },
  "macro": {
    "spy": {
      "price": 640.91,
      "change_1d_pct": 1.06,
      "change_7d_pct": 1.83
    },
    "vix": {
      "level": 14.73,
      "signal": "LOW_FEAR"
    },
    "treasury_10y": {
      "yield_pct": 4.29
    },
    "dollar_index": {
      "level": 98.1
    },
    "gold": {
      "price": 3348.9
    },
    "regime": "BULL_NORMAL"
  },
  "news": [
    {
      "headline": "J&J's MedTech Unit Sales Improve in Q2: Will the Upside Continue?",
      "source": "Yahoo",
      "datetime": 1755000840,
      "summary": "Johnson & Johnson's Q2 MedTech sales beat estimates, fueled by cardiovascular gains, surgical vision growth and new product momentum.",
      "url": "https://finnhub.io/api/news?id=32ba43e416a62973a55c0e38baf415158e7527a24a19773743c353f9c87bc87c"
    },
    {
      "headline": "Multiple Myeloma Market Trends and Company Analysis Report 2025-2033 Featuring BMS, Novartis, Abbvie, Sanofi, Johnson and Johnson, Baxter, Pfizer, and Takeda",
      "source": "Yahoo",
      "datetime": 1754996340,
      "summary": "The Global Multiple Myeloma Market is projected to grow from USD 21.78 billion in 2024 to USD 40.41 billion by 2033, at a CAGR of 7.11%. Growth drivers include rising multiple myeloma cases, advances in targeted therapies like monoclonal antibodies, and the increasing adoption of immunotherapies. En",
      "url": "https://finnhub.io/api/news?id=935f341a4411b701496e42970e26df9cbaf2110b44122724cea5bef64808ce44"
    },
    {
      "headline": "Puerto Rico\u2019s ongoing journey from manufacturing hub to innovation enterprise",
      "source": "Yahoo",
      "datetime": 1754981858,
      "summary": "Biotechs are coming to the island as tariffs threaten overseas drug exports, and finding Puerto Rico is more than just a leading manufacturing hub.",
      "url": "https://finnhub.io/api/news?id=18e0825ddcf3a73b36aaf4db3edfe28c1dc6e27844d9a3c8b70ef5ce0c7c83b0"
    },
    {
      "headline": "Merck's Narrowed 2025 Sales View: What it Means After Q2 Results?",
      "source": "Yahoo",
      "datetime": 1754926320,
      "summary": "MRK trims its 2025 sales range but lifts the lower end of its EPS outlook. Keytruda, Animal Health and new drugs are expected to drive a second-half rebound.",
      "url": "https://finnhub.io/api/news?id=d442286596621996ceafd5dc69f37ccb03f38b5bdff8a45c6c1d96394132cfec"
    },
    {
      "headline": "Wasatch Global Value Fund Q2 2025 Commentary",
      "source": "SeekingAlpha",
      "datetime": 1754920680,
      "summary": "The Wasatch Global Value Fund\u00e2\u0080\u0094Investor Class returned 5.69% in the quarter, slightly underperforming the MSCI AC World Value Index, which returned 5.84%.",
      "url": "https://finnhub.io/api/news?id=0d237a15b93b61b690ce7b4e090cc715672c9b063b8df0714337e96a2aec5daf"
    }
  ],
  "news_count": 5,
  "sec_filings": [
    {
      "form": "10-Q",
      "date": "2025-07-24",
      "description": "jnj-20250629.htm",
      "url": "https://www.sec.gov/Archives/edgar/data/200406/000020040625000178/jnj-20250629.htm"
    },
    {
      "form": "13F-HR",
      "date": "2025-07-22",
      "description": "xslForm13F_X02/primary_doc.xml",
      "url": "https://www.sec.gov/Archives/edgar/data/200406/000090445425000367/xslForm13F_X02/primary_doc.xml"
    },
    {
      "form": "4",
      "date": "2025-07-18",
      "description": "xslF345X05/wk-form4_1752869553.xml",
      "url": "https://www.sec.gov/Archives/edgar/data/200406/000020040625000172/xslF345X05/wk-form4_1752869553.xml"
    },
    {
      "form": "8-K",
      "date": "2025-07-16",
      "description": "jnj-20250716.htm",
      "url": "https://www.sec.gov/Archives/edgar/data/200406/000020040625000170/jnj-20250716.htm"
    },
    {
      "form": "4",
      "date": "2025-06-12",
      "description": "xslF345X05/wk-form4_1749760336.xml",
      "url": "https://www.sec.gov/Archives/edgar/data/200406/000020040625000156/xslF345X05/wk-form4_1749760336.xml"
    }
  ],
  "sec_filings_count": 5,
  "data_quality": {
    "has_price": true,
    "has_technicals": true,
    "has_fundamentals": true,
    "has_macro": true,
    "has_news": true,
    "has_sec_filings": true
  }
}